Neoplasm Metastasis, Stomach Neoplasms
Conditions
Keywords
Prognosis, Multidisciplinary treatment, C-GCLM Classification, Gastric cancer, Liver metastasis
Brief summary
This multi-institutional retrospective cohort study aimed to describe and analyze the overall clinical characteristics, therapeutic status and prognosis pattern of gastric cancer liver metastasis (GCLM) in China.
Interventions
PROCEDUREGastrectomy; Hepatectomy
Sponsors
Chinese PLA General Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Gastric cancer liver metastases cases aged over 18 years old; * Primary gastric carcinoma (including different histopathological types) confirmed by biopsy or surgery (pre-, intra- or post- treatment); * In hospital cases between 2020/01/01 to 2019/12/3.
Exclusion criteria
* Poor compliance to treatment or lost to follow-up; * Gross loss of clinical data.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 1-year overall survival | 2011/01/01-2020/12/31 | The proportion (%) of gastric cancer liver metastasis patients that survived beyond one-year follow-up period. |
| 3-year overall survival | 2011/01/01-2021/12/31 | The proportion (%) of gastric cancer liver metastasis patients that survived beyond three-year follow-up period. |
| 5-year overall survival | 2011/01/01-2021/12/31 | The proportion (%) of gastric cancer liver metastasis patients that survived beyond five-year follow-up period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The incidence of gastric cancer liver metastasis cases | 2010/01/01-2019/12/31 | The rate of gastric cancer liver metastasis cases divided by all gastric cancer cases in the study period. |
| The prognostic predictive value for patients with different C-GCLM classification | 2010/01/01-2019/12/31 | The proportion (%) of patients of different classification that survived beyond specific follow-up period. |
| The proportion for synchronous and metachronous liver metastases cases | 2010/01/01-2019/12/31 | The proportion (%) of synchronous or metachronous gastric cancer liver metastases cases in all gastric cancer cases |
| The survival of patients that recieved different therapeutic methods | 2010/01/01-2019/12/31 | The proportion (%) of patients under different therapies that survived beyond specific follow-up period. |
Countries
China
Outcome results
None listed